About Conference
OMICS International is a renowned organization that organizes highly recognizable conferences throughout the world. OMICS International is currently bringing forth “International Conference and Expo on Generic Drug Market and Contract Manufacturing’’ (Generic Pharma 2016) slated on Oct 31- Nov 02, 2016 at Barcelona, Spain.
OMICS International is a renowned organization that organizes highly notable pharmaceutical conferencesthroughout the globe.
OMICS International organizes 600+ Conferences every year across USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access journals which contain over 70000 eminent personalities, reputed scientists as editorial board members, 1200 Symposium & Workshops and 5 million followers. To know more about the conference series visit: http://conferenceseries.com/. To its credit OMICS International invites all the participants across the globe to attend the "International Conference and Expo on Generic Drug Market and Contract Manufacturing’’.
Generic Pharma 2016 conveys recent developments in Generic drug marketing and production of generic drugs and contract manufacturing. A complete knowledge of a scientific discipline that described the effects of generic drug marketing and generic Pharma now explores the Scope of generic drug marketing in industry. Generic Pharma 2016 provides detailed market, technology, and industry analyses to help readers quantify and qualify the market for prescription generic drugs. Important trends are identified and sales forecasts by product categories and major country markets these are based on industry sources and considered assessment of the regulatory environment, healthcare policies, demographics, and other factors that directly affect the generic drug market. The wider economic environment is also taken into account.
The scope of Generic Pharma discusses the implications of all the above-mentioned trends, in the context of the current size and growth of the generics market, both in global terms and analysed by the most important national markets. The nature and structure of the generics industry is discussed, and an update on M&A activity. With first-generation biopharmaceutical products reaching the end of their patent lives, a whole new market field—bio generics or bio similar is opening up, for those generics companies capable of (or prepared to buy-in) the technological expertise required. The international landscape is changing for generics as for all pharmaceuticals. China, India, Eastern European countries and Brazil are among rising centres of generic activity.
Conference Highlights
- Generic Drugs
- Generic Pills and Generic Medication
- Office of Generic Drugs (OGD)
- Global Generic Trends
- Biosimilars
- Drug Discovery & Designing
- Preformulation Studies
- Advances in Contract Manufacturing
- Interactive and Electronic Contract Manufacturing
- GMP, GCP and Quality Control
- Regulatory Affairs and IPR
- Generic Drug Market
- Contracted Drug Production
- Generic Drug Marketing strategy
- Integrated Supply Chain Management and Logistics
- Entrepreneurs Investment Meet
Special Issues
- All accepted abstracts will be published in respective OMICS International Journals.
- Abstracts will be provided with Digital Object Identifier by Cross Ref.
